Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Synergy CHC Corp./ 8-K

Current Report · Items 1.03, 5.02 · 8-K

Synergy CHC Corp.

Bankruptcy or Receivership · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 1.03 Bankruptcy or Receivership. On September 4, 2026, Synergy CHC Corp. (the “Company”) filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Columbia (the “Bankruptcy Court”). The chapter 11 case is captioned In re Synergy CHC Corp., Case No. 26-465-ELG.…

Filed Sep 8, 2026Accepted Sep 4, 2026, 7:50 PM EDTCIK 1562733Accession 0001213900-26-097802
View company →Permanent SEC source ↗
Share

Company context

We are a provider of consumer health care, beauty, and lifestyle products. Our current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement (this study was performed independently and is not related to any U.S. Food and Drug Administration (“FDA”) -approved investigational new drug (IND) application) that has been shown to improve memory, concentration and focus, and Flat Tummy, a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals. Collectively, these brands are referred to as nutraceuticals. Our products are sold through some of the nation’s leading club, mass drug, and other retailers such as Costco, Amazon.com, Walmart, Walgreens, BJ’s, and The Vitamin Shoppe. Additionally, we have expanded into Canada and Mexico.

Current securities

SNYRNASDAQ · EQUITY · CurrentSNYRQOTC · EQUITY · Current
Historical securities (1)
SNYRDOTC · EQUITY · Historical · closed Oct 4, 2024

Recent company filings

  1. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingSep 16, 2026
  2. Triggering Events That Accelerate or Increase a Direct Financial ObligationAug 26, 2026
  3. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD DisclosureAug 21, 2026
  4. Triggering Events That Accelerate or Increase a Direct Financial ObligationAug 11, 2026
  5. Other EventsJul 29, 2026

Disclosure sections

Items 1.03, 5.02

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.03Item 1.03 - Bankruptcy or Receivership
Item 1.03 Bankruptcy or Receivership. On September 4, 2026, Synergy CHC Corp. (the “Company”) filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Columbia (the “Bankruptcy Court”). The chapter 11 case is captioned In re Synergy CHC Corp., Case No. 26-465-ELG. As a result of the chapter 11 filing, the Company’s assets became subject to the jurisdiction of the Bankruptcy Court. The Company, operating as a debtor-in-possession, reasonably anticipates filing a plan of liquidation or reorganization within the forthcoming 120-day period. A meeting of creditors will be scheduled in accordance with the applicable provisions of the Bankruptcy Code and the Federal Rules of Bankruptcy Procedure. The Company has engaged the services of The VerStandig Law Firm, LLC, which is acting as the Company’s counsel and advisor in connection with the bankruptcy case and which will continue to act in said capacity pending approval from the Bankruptcy Court.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective August 26, 2026, the Company engaged the services of Lauren P. Berret of Eisner Advisory Group LLC as chief restructuring officer. Effective September 4, 2026, immediately following the filing of the chapter 11 petition described under Item 1.03 above, Alfred Baumeler, Nitin Kaushal, J. Paul SoRelle and Teresa Thompson resigned as members of the Company’s Board of Directors. The resignations were not the result of any disagreement with the Company regarding the Company’s operations, policies or practices. The directors resigned in connection with the Company’s chapter 11 filing. Following the resignations, the sole person serving on the Company’s Board of Directors is Jack Ross. Effective August 31, 2026, Alfred Baumeler resigned as President.